Compare Segar Kumala Indonesia Tbk (BUAH) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Segar Kumala Indonesia Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Segar Kumala Indonesia Tbk trades at Rp515 (market cap 1.02T, 63.4K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp167 (market cap 651.75B, 627.2K 24h volume). The key difference: Segar Kumala Indonesia Tbk is the larger of the two by market cap, and UBC Medical Indonesia Tbk. is more actively traded (627.2K versus 63.4K). Which is the better fit depends on your goals.
| BUAH | LABS | |
|---|---|---|
Market Cap | 1.02T | 651.75B |
Volume | 63.4K | 627.2K |
Lot | 634 | 6.27K |
Turnover | 32.29M | 103.65M |
Average Price | 509.27 | 165.25 |
Value | 32.29M | 103.65M |
Indicative Equilibrium Price | 510 | 165 |
Indicative Equilibrium Volume | 400 | 300 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Segar Kumala Indonesia Tbk
PT Segar Kumala Indonesia Tbk (“the Company”) was established based on Notarial Deed of P. Sutrisno A. Tampubolon, No. 14 dated June 10, 2017.
Read more on BUAH →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
